Livforsakringsbolaget Skandia, Omsesidigt Abb Vie Inc. Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

$1.72 Billion
Q3 2024

A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Abb Vie Inc. stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 109,970 shares of ABBV stock, worth $19.3 Million. This represents 1.26% of its overall portfolio holdings.

Number of Shares

109,970

Previous 76,185 44.35%

Holding current value

$19.3 Million

Previous $13.1 Million 66.19%

% of portfolio

1.26%

Previous 1.07%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$163.84 - $199.33 $5.54 Million - $6.73 Million	33,785 Added 44.35%	109,970 $21.7 Million
Q2 2024 Jul 15, 2024	BUY	$154.79 - $180.76 $254,474 - $297,169	1,644 Added 2.21%	76,185 $13.1 Million
Q1 2024 Apr 23, 2024	BUY	$159.82 - $182.1 $974,902 - $1.11 Million	6,100 Added 8.91%	74,541 $13.6 Million
Q4 2023 Jan 31, 2024	BUY	$137.6 - $154.97 $243,414 - $274,141	1,769 Added 2.65%	68,441 $10.6 Million
Q3 2023 Oct 20, 2023	SELL	$133.59 - $154.65 $400,770 - $463,950	-3,000 Reduced 4.31%	66,672 $9.94 Million
Q2 2023 Jul 06, 2023	SELL	$132.51 - $164.9 $914,318 - $1.14 Million	-6,900 Reduced 9.01%	69,672 $9.39 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $13,277 - $15,923	-96 Reduced 0.13%	76,572 $12.4 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $2.8 Million - $3.22 Million	-20,900 Reduced 21.42%	76,668 $10.3 Million
Q2 2022 Aug 16, 2022	SELL	$137.62 - $174.96 $853,244 - $1.08 Million	-6,200 Reduced 5.97%	97,568 $14.9 Million
Q1 2022 Jun 21, 2022	BUY	$131.98 - $163.75 $1.57 Million - $1.95 Million	11,900 Added 12.95%	103,768 $16.8 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $612,351 - $774,801	-5,700 Reduced 5.84%	91,868 $12.4 Million
Q3 2021 Oct 28, 2021	SELL	$106.4 - $120.78 $468,160 - $531,432	-4,400 Reduced 4.32%	97,568 $10.5 Million
Q2 2021 Jul 13, 2021	BUY	$105.21 - $117.21 $757,512 - $843,912	7,200 Added 7.6%	101,968 $11.5 Million
Q1 2021 May 07, 2021	BUY	$102.3 - $112.62 $2.39 Million - $2.63 Million	23,350 Added 32.69%	94,768 $10.3 Million
Q4 2020 Mar 02, 2021	BUY	$80.49 - $108.67 $845,145 - $1.14 Million	10,500 Added 17.24%	71,418 $7.65 Million
Q3 2020 Nov 09, 2020	SELL	$85.91 - $100.83 $154,638 - $181,494	-1,800 Reduced 2.87%	60,918 $5.34 Million
Q2 2020 Jul 08, 2020	BUY	$73.37 - $98.18 $1.03 Million - $1.37 Million	13,971 Added 28.66%	62,718 $6.16 Million
Q1 2020 Apr 22, 2020	BUY	$64.5 - $97.79 $290,250 - $440,055	4,500 Added 10.17%	48,747 $3.71 Million
Q4 2019 Jan 28, 2020	SELL	$72.13 - $90.25 $403,928 - $505,400	-5,600 Reduced 11.23%	44,247 $3.92 Million
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $768,356 - $923,784	-12,200 Reduced 19.66%	49,847 $3.78 Million
Q2 2019 Jul 19, 2019	BUY	$65.7 - $83.98 $144,540 - $184,756	2,200 Added 3.68%	62,047 $4.51 Million
Q1 2019 May 09, 2019	BUY	$77.14 - $90.79 $107,996 - $127,106	1,400 Added 2.4%	59,847 $4.82 Million
Q3 2018 Oct 26, 2018	SELL	$88.91 - $98.84 $1.98 Million - $2.2 Million	-22,300 Reduced 27.62%	58,447 $5.53 Million
Q2 2018 Jul 10, 2018	BUY	$89.78 - $106.23 $233,428 - $276,198	2,600 Added 3.33%	80,747 $7.48 Million
Q4 2017 Jan 18, 2018	SELL	$89.56 - $98.21 $922,468 - $1.01 Million	-10,300 Reduced 11.65%	78,147 $7.56 Million
Q3 2017 Oct 12, 2017	BUY	$69.85 - $89.22 $6.18 Million - $7.89 Million	88,447	88,447 $7.86 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.

Account

Livforsakringsbolaget Skandia, Omsesidigt Abb Vie Inc. Transaction History